Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.
Published September 14, 2016 · Recall initiated: June 17, 2016
Summary
FDA records drug Class II recall D-1496-2016, published September 14, 2016 and initiated June 17, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 14,661 vials; Lot: All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva North America
- Distributor
- Nationwide and Puerto Rico
- Lot
- All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClaravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules EachOctober 12, 2016
- FDALinezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., NorthSeptember 14, 2016
- FDAARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary forSeptember 14, 2016
- FDAOndansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALSSeptember 14, 2016
- FDAEphedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC:September 14, 2016
- FDABromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd.,September 14, 2016
Questions about this recall
Was Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01. recalled?
Yes. FDA published recall D-1496-2016 on September 14, 2016. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter